Arcus Biosciences, Inc.

NYSE:RCUS

10.59 (USD) • At close August 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 160282648391453132292533.655332718354.4999.4619.4619.4619.48764.531.751.759.751.751.751.751.5624.2911.251.251.250.16300
Cost of Revenue 0000000000000000000000000000000000
Gross Profit 160282648391453132292533.655332718354.4999.4619.4619.4619.48764.531.751.759.751.751.751.751.5624.2911.251.251.250.16300
Gross Profit Ratio 1111111111111111111111111111111100
Reseach & Development Expenses 1391221011231151099382848180.277706149.93671.25468.77166.38748.71251.80135.69323.14220.68617.24124.99915.55411.43612.85913.69911.65212.14621.4357.8345.804
General & Administrative Expenses 2928283030322930283027.89626262423.29616.34316.82615.82112.78711.17711.4327.0086.5917.7585.9114.9693.613.5773.452.9292.4481.8621.831.496
Selling & Marketing Expenses 0000000000000000000000000000000000
SG&A 2928283030322930283027.89626262423.29616.34316.82615.82112.78711.17711.4327.0086.5917.7585.9114.9693.613.5773.452.9292.4481.8621.831.496
Other Expenses 00000200000000000000000000000000000
Operating Expenses 168150129153145161122112112111108.096103968573.23287.59785.59782.20861.49962.97847.12530.1527.27724.99930.9120.52315.04616.43617.14914.58114.59423.2979.6647.3
Operating Income -8-122-103-105-106-16-91-80-83-86-74.441-70-69-67281.267-78.136-76.136-72.747-52.0121.552-45.375-28.4-17.527-23.249-29.16-18.773-13.484-12.145-15.899-13.331-13.344-23.134-9.664-7.3
Operating Income Ratio -0.05-4.357-3.962-2.188-2.718-0.11-2.935-2.5-2.862-3.44-2.212-2.121-2.556-3.7220.793-8.259-8.047-7.689-5.4820.024-25.929-16.229-1.798-13.285-16.663-10.727-8.633-2.83-12.719-10.665-10.675-141.92600
Total Other Income Expenses Net 01091313121111986.981520-0.0840.1610.1660.1540.1590.270.3010.6470.9290.8971.071.1031.1891.3332.3660.3770.1340.0120.1140.1
Income Before Tax -8-112-94-92-93-4-80-69-74-78-67.46-65-67-67281.183-77.975-75.97-72.593-51.8531.822-45.074-27.753-16.598-22.352-28.09-17.67-12.295-10.812-13.533-12.954-13.21-23.122-9.55-7.2
Income Before Tax Ratio -0.05-4-3.615-1.917-2.385-0.028-2.581-2.156-2.552-3.12-2.004-1.97-2.481-3.7220.793-8.242-8.03-7.673-5.4660.028-25.757-15.859-1.702-12.773-16.051-10.097-7.871-2.52-10.826-10.363-10.568-141.85300
Income Tax Expense 0010001212-0.0040011.8150000000000000000000
Net Income -8-112-94-92-93-4-81-71-75-80-67.456-65-67-68279.368-77.975-75.97-72.593-51.8531.822-45.074-27.753-16.598-22.352-28.09-17.67-12.295-10.812-13.533-12.954-13.21-23.122-9.55-7.2
Net Income Ratio -0.05-4-3.615-1.917-2.385-0.028-2.613-2.219-2.586-3.2-2.004-1.97-2.481-3.7780.788-8.242-8.03-7.673-5.4660.028-25.757-15.859-1.702-12.773-16.051-10.097-7.871-2.52-10.826-10.363-10.568-141.85300
EPS 0-1.14-1.03-1.01-1.02-0.046-1.08-0.95-1.02-1.1-0.92-0.84-0.9-0.963.97-1.11-1.09-1.08-0.820.03-0.93-0.63-0.38-0.51-0.64-0.41-0.28-0.25-0.32-1.37-0.54-0.94-0.39-0.29
EPS Diluted 0-1.14-1.03-1.01-1.02-0.046-1.08-0.95-1.02-1.1-0.92-0.84-0.9-0.963.71-1.11-1.09-1.08-0.820.03-0.93-0.63-0.38-0.51-0.64-0.41-0.28-0.25-0.32-1.37-0.54-0.94-0.39-0.29
EBITDA 4-108-89-89-910-77-67-72-75-65.419-63-64-66281.924-77.012-75.15-71.793-50.1922.552-44.438-27.414-16.671-22.363-28.277-17.82-12.537-11.171-14.984-12.503-12.578-22.402-9.036-6.814
EBITDA Ratio 0.025-3.857-3.423-1.854-2.3330-2.484-2.094-2.483-3-1.944-1.909-2.37-3.6670.795-8.14-7.943-7.588-5.2910.04-25.393-15.665-1.71-12.779-16.158-10.183-8.026-2.603-11.987-10.002-10.062-137.43600